TissGeneSummary for RAD9B |
Gene summary |
Basic gene information | Gene symbol | RAD9B |
Gene name | RAD9 homolog B (S. pombe) | |
Synonyms | - | |
Cytomap | UCSC genome browser: 12q24.11 | |
Type of gene | protein-coding | |
RefGenes | NM_001286531.1, NM_001286532.1,NM_001286533.1,NM_001286534.1,NM_001286535.1, NM_001286536.1,NM_152442.3, | |
Description | DNA repair exonuclease rad9 homolog Bcell cycle checkpoint control protein RAD9B | |
Modification date | 20141207 | |
dbXrefs | MIM : 608368 | |
HGNC : HGNC | ||
Ensembl : ENSG00000151164 | ||
Vega : OTTHUMG00000152952 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_RAD9B | |
BioGPS: 144715 | ||
Pathway | NCI Pathway Interaction Database: RAD9B | |
KEGG: RAD9B | ||
REACTOME: RAD9B | ||
Pathway Commons: RAD9B | ||
Context | iHOP: RAD9B | |
ligand binding site mutation search in PubMed: RAD9B | ||
UCL Cancer Institute: RAD9B | ||
Assigned class in TissGDB* | B | |
Included tissue-specific gene expression resources | HPA,TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of RAD9B | ||
Description by TissGene annotations | Cancer gene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for RAD9B |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for RAD9B |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for RAD9B |
TissGeneSNV for RAD9B |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.Q219E | BLCA | 1 |
p.R26G | LUAD | 1 |
p.S282G | PAAD | 1 |
p.R295* | STAD | 1 |
p.A277S | ESCA | 1 |
p.R105I | UCEC | 1 |
p.Q176E | STAD | 1 |
p.D45N | SKCM | 1 |
p.D216H | UCEC | 1 |
p.V210A | BLCA | 1 |
p.Q293H | UCEC | 1 |
p.F414L | UCEC | 1 |
p.Q147E | BLCA | 1 |
p.S30F | SKCM | 1 |
p.F320L | SKCM | 1 |
p.K256E | LIHC | 1 |
p.H83Y | UCEC | 1 |
p.S285G | PAAD | 1 |
p.T8A | SKCM | 1 |
p.F125L | UCEC | 1 |
p.E358G | THYM | 1 |
p.A273P | ACC | 1 |
p.I317T | PAAD | 1 |
p.G183E | SKCM | 1 |
p.S354G | PAAD | 1 |
p.K416R | SKCM | 1 |
p.I247L | KIRC | 1 |
p.I247R | KIRC | 1 |
p.D299N | CESC | 1 |
p.E286* | PRAD | 1 |
p.A345P | ACC | 1 |
p.D299N | LIHC | 1 |
p.R223Q | SKCM | 1 |
p.D227N | LIHC | 1 |
p.M159I | LUSC | 1 |
p.S314F | BLCA | 1 |
p.V121L | COAD | 1 |
p.P214R | HNSC | 1 |
p.F392L | SKCM | 1 |
p.S321F | BLCA | 1 |
p.E169K | SKCM | 1 |
p.E108* | UCEC | 1 |
p.F342V | SKCM | 1 |
p.R111I | UCEC | 1 |
p.K319T | KIRP | 1 |
p.V138A | BLCA | 1 |
p.R133I | UCEC | 1 |
p.S288L | CESC | 1 |
p.R253K | SKCM | 1 |
Top |
TissGeneCNV for RAD9B |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for RAD9B |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | EL594131 | RAD9B-B2M | chr12:110954428 | chr15:45007661 |
Top |
TissGeneNet for RAD9B |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for RAD9B |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for RAD9B |
TissGeneDrug for RAD9B |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for RAD9B |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0036631 | Seminoma | 1 | BeFree |